BOSTON – With Roche’s acquisition of 454 Life Sciences expected to close this quarter, CuraGen and 454 founder and former chairman Jonathan Rothberg isn’t wasting any time with his latest entrepreneurial venture.
  
RainDance Technologies, a lab-on-a-chip startup he co-founded in 2004, recently raised $23.7 million in first-round venture financing and plans to deliver the first version of its platform to customers later this year. 
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.